SGLT-2-inhibitors in patients with cardiac wild-type ATTR-amyloidosis

被引：0
|
作者：
Barzen, Gina [1 ,2 ]
Kugel, Elias [2 ]
Roemmelt, Constantin [2 ]
Mattig, Isabel [2 ]
Hahn, Katrin [2 ]
Spethmann, Sebastian [1 ]
机构：
[1] Free Univ Berlin, Berlin, Germany
[2] Charite, Deutsch Herzzentrum, Dept Cardiol Angiol & Intens Care Med, Berlin, Germany
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
41
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [41] Right Ventricular Involvement In Wild-type Transthyretin Cardiac Amyloidosis
    Vinnakota, Shravya
    Ali, Mays T.
    Chang, Ian C.
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 701 - 701
  • [42] Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg
    Broussier, Amaury
    David, Jean Philippe
    Kharoubi, Mounira
    Oghina, Silvia
    Segaux, Lauriane
    Teiger, Emmanuel
    Laurent, Marie
    Fromentin, Isabelle
    Bastuji-Garin, Sylvie
    Damy, Thibaud
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [43] CARDIAC SARCOIDOSIS OR WILD-TYPE TRANSTHYRETIN AMYLOIDOSIS: WHAT IS THE DIAGNOSIS?
    Jawaid, Anas
    Naqvi, Syed Y.
    Arazoza, Eduardo A.
    Storozynsky, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 2653 - 2653
  • [44] Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis
    Nicolò Martini
    Stefania Rizzo
    Cristiano Sarais
    Alberto Cipriani
    BMC Cardiovascular Disorders, 20
  • [45] Incidence and predictors of worsening heart failure in patients with wild-type transthyretin cardiac amyloidosis
    Ladefoged, Bertil Thyrsted
    Dybro, Anne
    Dahl Pedersen, Anders Lehmann
    Rasmussen, Torsten Bloch
    Vase, Henrik olholm
    Clemmensen, Tor Skibsted
    Gillmore, Julian
    Poulsen, Steen Hvitfeldt
    ESC HEART FAILURE, 2022, 9 (05): : 2978 - 2987
  • [46] Evolution over time of echocardiographic features in patients with wild-type transthyretin cardiac amyloidosis
    Sanna, Giuseppe Damiano
    Milani, Paolo
    Perlini, Stefano
    Fogliani, Alessandro
    Guida, Gianluigi
    Attanasio, Andrea
    Foli, Andrea
    Basset, Marco
    Benvenuti, Pietro
    Nanci, Martina
    Baragli, Anna Carnevale
    Mussinelli, Roberta
    Obici, Laura
    Nuvolone, Mario
    Casu, Gavino
    Merlini, Giampaolo
    Palladini, Giovanni
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S212 - S213
  • [47] As Good as it Gets: SGLT2 Inhibitors in Cardiac Amyloidosis
    Pinney, Sean P.
    Costanzo, Maria Rosa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (24) : 2423 - 2425
  • [48] Role of Cardiac Implantable Device Therapy in Patients With ATTR Wild Type Amyloidosis : A Retrospective Analysis of Mortality Outcomes
    Padmanabhan, Deepak
    Chahal, Anwar
    Knight, Jennifer
    Tandon, Nidhhi
    Chacko, Paul
    Somers, Virend K.
    Dispenzieri, Angela
    Grogan, Martha
    Brady, Peter
    Lin, Grace
    CIRCULATION, 2016, 134
  • [49] Stabilization of Cardiac Function in Wild-Type Transthyretin Cardiac Amyloidosis With Diflunisal.
    Lohrmann, Graham
    Pipilas, Alexandra
    Mussinelli, Roberta
    Gopal, Deepa M.
    Berk, John L.
    Connors, Lawreen H.
    Vellanki, Nirupama
    Hellawell, Jennifer
    Siddiqi, Omar K.
    Fox, Jonathan
    Ruberg, Frederick L.
    CIRCULATION, 2018, 138
  • [50] Potential hematopoietic effects of SGLT2 inhibitors in patients with cardiac amyloidosis.
    Ermolaev, Nikita
    Willixhofer, Robin
    Kronberger, Christina
    Rettl, Rene
    Binder, Christina
    Duca, Franz
    Nitsche, Christian
    Kammerlander, Andreas
    Poledniczek, Michael
    Gregshammer, Bernhard
    Ahmadi-Fazel, Diana
    Kastner, Johannes
    Bergler-Klein, Jutta
    Eslam, Roza Badr
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
12345